Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06603597
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-16
Brief Title:
HER2-positive Breast Cancer Registry
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prospective Evaluation of Outcomes for HER2-positive Breast Cancer PRO-HER2
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRO-HER2
Brief Summary:
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None